iNEXT aims to translate fundamental structural biology research into bio-scientific applications. iNEXT…
- Provides trans-national access to state-of-the-art infrastructures for structural biology.
- Stimulates access for non-structural biologists.
- Provides training to modern structural biology technology.
- Data collection for macromolecular X-ray crystallography (MX), solution scattering (SAXS), Nuclear Magnetic Resonance (NMR), Electron Microscopy (EM), Macromolecular interactions and Advanced Light Microscopy (ALM).
- Themes of access for expert users and non-structural biologists:
1. Structural Audit
2. Enhanced Support
3. High-End Data Collection
- Strengthening links between industrial and academic structural biologists.
- Promoting drug development by enabling ligand fragment screening methods for the discovery of chemical probes and hits.
iNEXT internal biomedical research activities promote integration of the infrastructures and expansion to new communities
- Structure-based small molecule inhibitor discovery (ligand screening).
- Integrated study of membrane proteins.
- Study of macromolecules and their complexes in cells.
Scientific Advisory Board
- iNEXT’s international Scientific Advisory Board is composed of high profile structural biologists with different scientific background and expertise:
- Bridget Carragher
Director Simons Electron Microscopy Center at New York Structural Biology Center
New York, USA
- Johan Garssen
Professor Immunopharmacology at Utrecht University, Director Platform Immunology at Nutricia Research
Utrecht, The Netherlands
- Astrid Gräslund
Professor of Biophysics at Stockholm University
- Jan Löwe
Deputy Director Medical Research Council – Laboratory of Molecular Biology (MRC-LMB)
Cambridge, United Kingdom
- Ray Stevens
Provost Professor of Biological Sciences and Chemistry at University of Southern California, Director of the Bridge Institute
Los Angeles, USA